ARCT
Arcturus Therapeutics Holdings Inc
Price:  
17.95 
USD
Volume:  
277,606.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ARCT WACC - Weighted Average Cost of Capital

The WACC of Arcturus Therapeutics Holdings Inc (ARCT) is 7.1%.

The Cost of Equity of Arcturus Therapeutics Holdings Inc (ARCT) is 10.20%.
The Cost of Debt of Arcturus Therapeutics Holdings Inc (ARCT) is 5.50%.

Range Selected
Cost of equity 6.90% - 13.50% 10.20%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 7.00% 5.50%
WACC 4.9% - 9.3% 7.1%
WACC

ARCT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.67 1.55
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 13.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 4.00% 7.00%
After-tax WACC 4.9% 9.3%
Selected WACC 7.1%